Cigna reaffirmed 2026 outlook while Cigna Group stock trades at EUR 254.15

Published on 10/13/2026 at 12:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna set fiscal 2026 adjusted EPS at USD 30.45 minimum. Cigna Group stock is EUR 254.15 versus EUR 251.90, plus 0.89 percent on October 13, 2026.

Cigna reaffirmed fiscal 2026 adjusted earnings per share guidance of at least USD 30.45 at its September 30 Investor Day.
The company also announced a USD 3.00 billion modernization and productivity initiative and a 10.00-14.00 percent adjusted earnings per share compound annual growth target through 2030.
Cigna Group stock was trading at EUR 254.15 at Lang & Schwarz on October 13, 2026, plus 0.89 percent versus the Xetra close of EUR 251.90 on October 12, 2026.
The Cigna Group is scheduled to publish third-quarter 2026 results on November 5, 2026.

Modernes Bürogebäude eines US-Krankenversicherers mit Glasfassade und gepflegtem Außengelände — Cigna Group Krankenversicherung modernes Unternehmensgebäude mit Glasfassade, ISIN US1255231003, Mitarbeiter gehen zum Eingang, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) was trading at EUR 254.15 at Lang & Schwarz on October 13, 2026, at 12:00 p.m. CEST, EUR 2.25 and plus 0.89 percent above the Xetra close of October 12, 2026, at EUR 251.90. At its September 30, 2026, Investor Day, the company reaffirmed fiscal 2026 adjusted earnings per share of at least USD 30.45 and presented a longer-term growth plan, according to Yahoo Finance.

Three milestones shape the outlook

On July 30, 2026, Cigna reported second-quarter total revenue of USD 71.70 billion and adjusted earnings per share of USD 7.78, according to Yahoo Finance. The same quarter produced GAAP diluted earnings per share of USD 6.29 in the standardized financial statements, while revenue increased from USD 68.49 billion in the first quarter of 2026 to USD 71.67 billion in the second quarter.

On September 30, 2026, Cigna reaffirmed adjusted revenue of approximately USD 280.00 billion for fiscal 2026 and set a medical care ratio range of 83.70-84.70 percent. On October 6, 2026, Cigna Healthcare introduced Health Sense, with a phased rollout for eligible customers with oncology and cardiometabolic needs planned for early 2027, according to Cigna Healthcare.

What does the 10.00-14.00 percent target mean?

The Investor Day plan targets adjusted earnings per share compound annual growth of 10.00-14.00 percent through 2030 and cumulative operating cash flow of approximately USD 50.00 billion. Cigna also announced a USD 3.00 billion multi-year modernization and productivity initiative focused on process upgrades, artificial intelligence tools, and supplier management.

The financial picture is split between durable specialty growth and execution risk in pharmacy benefits. In the second quarter of 2026, Specialty and Care Services delivered pre-tax adjusted earnings growth of 22.00 percent year over year, while Cigna Healthcare revenue grew 10.00 percent year over year to USD 11.80 billion. The medical care ratio was 84.50 percent for that quarter, a key measure of claims costs against premiums.

November 5 brings the next test

The Cigna Group is scheduled to release third-quarter 2026 results on November 5, 2026, with management's conference call beginning at 8:30 a.m. ET, according to Yahoo Finance. That report will test whether specialty performance continues to offset pressure from slower GLP-1 prescription growth and the transition to Cigna's rebate-free Signature model.

Stock stays below its yearly high

Cigna Group's primary-market quote was USD 283.34 at 4:00 p.m. ET on October 12, 2026, while the 52-week range was USD 239.51 to USD 311.34. The USD 74.90 billion market capitalization and the distance from the yearly high put the EUR 254.15 Lang & Schwarz quote in a valuation context, but the euro move in this article is measured only against the Xetra close of October 12, 2026.

At Lang & Schwarz, Cigna Group stock was trading at EUR 254.15 on October 13, 2026, at 12:00 p.m. CEST, EUR 2.25 and plus 0.89 percent versus the Xetra close of October 12, 2026, at EUR 251.90. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.